BlackRock, Inc. (BLK) 13D/13G Filings for Decibel Therapeutics, Inc. (DBTX)

BlackRock, Inc. 13D and 13G filings for Decibel Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-03
12:09 pm
Purchase
2022-12-3113GDecibel Therapeutics, Inc.
DBTX
BlackRock Inc.
BLK
1,805,108
7.200%
1,805,108increase
(New Position)
Filing